Picture of ProSomnus logo

OSAPQ — ProSomnus News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Updated Clinical Trial Data Indicates Precision Oral Appliance Therapy With Prosomnus Devices Is Non-Inferior To Cpap Therapy For The Treatment Of Moderate To Severe Obstructive Sleep Apnea

Aug 23 (Reuters) - 
  
    * UPDATED CLINICAL TRIAL DATA INDICATES PRECISION ORAL
APPLIANCE
THERAPY WITH PROSOMNUS DEVICES IS NON-INFERIOR TO CPAP THERAPY
FOR THE TREATMENT OF MODERATE TO SEVERE OBSTRUCTIVE SLEEP APNEA
    * PROSOMNUS INC -  FIRST LINE OBSTRUCTIVE SLEEP APNEA
TREATMENT
STUDY (FLOSAT) IS ON TRACK TO ACHIEVE ALL ENDPOINTS
    * PROSOMNUS INC - PATIENTS ARE ACTIVELY BEING ENROLLED IN
SEVERE
OSA STUDY
    * PROSOMNUS INC - RESULTS OF STUDY INDICATE THAT PRECISION
OAT
WITH PROSOMNUS DEVICES IS AN EFFECTIVE, AND PREFERRED, OPTION
FOR PATIENTS

Source text for Eikon:  ID:nGNXbnWpQ4 
Further company coverage:  OSA.O 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on ProSomnus

See all news